Skip to content

Clazosentan

CARDIOVASCULAR SYSTEM

Also known as: ACT-108475, AXV-034343, clazosentan sodium, pivlaz, Ro 61-1790, VML 588

PMDA approvedATC C04AX33

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Clazosentan is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2022. DrugCentral lists 2 molecular targets, including EDNRA and EDNRB. Recorded indications include Prevention of cerebrovascular spasm.

  • Molecular targets: EDNRA and EDNRB (2 listed in DrugCentral).
  • Indications: Prevention of cerebrovascular spasm.
  • ATC code: C04AX33 (Other peripheral vasodilators).
  • Molecular formula: C25H23N9O6S; molecular weight 577.58 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Prevention of cerebrovascular spasm

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Endothelin-1 receptorEDNRAantagonistKi 9.89
Endothelin B receptorEDNRBunknownKi 6.76

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2022-01-20PMDA—IDORSIA PHARMACEUTICALS JAPAN LTD

ATC classification

ATC codeTherapeutic hierarchy
C04AX33CARDIOVASCULAR SYSTEM › PERIPHERAL VASODILATORS › PERIPHERAL VASODILATORS › Other peripheral vasodilators

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Clazosentan is on its molecule page.

Molecular formulaC25H23N9O6S
Molecular weight577.58 g/mol
CAS number180384-56-9
InChIKeyLFWCJABOXHSRGC-UHFFFAOYSA-N
PubChem CID6433095
COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=NC=C(C)C=C2)N=C(N=C1OCCO)C1=CC=NC(=C1)C1=NN=NN1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Clazosentan used for?

DrugCentral lists the following indications for Clazosentan: Prevention of cerebrovascular spasm.

How does Clazosentan work?

Its molecular targets in DrugCentral include EDNRA (antagonist) and EDNRB.

When was Clazosentan first approved?

Clazosentan was first approved by the PMDA in 2022.

What is the chemical formula of Clazosentan?

Clazosentan has the molecular formula C25H23N9O6S and a molecular weight of 577.58 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2022-01-20
AgencyPMDA
Targets2
Indications1
FormulaC25H23N9O6S
DrugCentral ID5518
Interactive profile